FK-506, A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM A STREPTOMYCES II. IMMUNOSUPPRESSIVE EFFECT OF FK-506 <i>IN VITRO</i>

TORU KINO; HIROSHI HATANAKA; SUSUMU MIYATA; NORIAKI INAMURA; MICHIHISA NISHIYAMA; TOSHIMI YAJIMA; TOSHIO GOTO; MASAKUNI OKUHARA; MASANOBU KOHSAKA; HATSUO AOKI; TAKENORI OCHIAI

doi:10.7164/antibiotics.40.1256

Abstract

The immuno-pharmacological profile of a novel immunosuppressive agent, FK-506 produced by a streptomycete, is presented here. We proceeded to test the effect of the agent on various in vitro immune systems. It showed that mixed lymphocyte reaction, cytotoxic T cell generation, the production of T cell-derived soluble mediators such as interleukin 2 (IL-2), interleukin 3 and gamma-interferon and the expression of the IL-2 receptor were suppressed by this agent. The IC₅₀ values of FK-506 and ciclosporin (CS) in all tests were approximately 0.1nM and 10nM, respectively. Therefore, the novel agent, FK-506 suppressed in vitro immune systems at about hundred times lower concentration than CS.

References (16)

1) KINO, T.; H. HATANAKA, M. HASHIMOTO, M. NISHIYAMA, T. GOTO, M. OKUHARA, M. KOHSAKA, H. AOKI & H. IMANAKA: FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiotics 40: 1249-1255, 1987

2) CALNE, R. Y.; D. J. G. WHITE, D. B. EVANS, S. THIRU, R. G. HENDERSON, D. V. HAMILTON, K. ROLLES, P. MCMASTER, T. J. DUFFY, B. R. D. MACDOUGALL & R. WILLIAMS: Cyclosporin A in cadaveric organ transplantation. Br. Med. J. 282: 934-936, 1981

3) WHITE, D. J. G.: Cyclosporin A: Clinical pharmacology and therapeutic potential. Drugs 24: 322-334, 1982

4) BUNJES, D.; C. HARDT, M. ROLLINGHOFF & H. WAGNER: Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur. J. Immunol. 11: 657-661, 1981

5) THOMSON, A.; W. D. K. MOON, C. L. GECZY & D. S. NELSON: Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology 48: 291-299, 1983

6) LARSSON, E.: Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J. Immunol. 124: 2828-2833, 1980

7) PALACIOS, R.: Concanavalin A triggers T lymphocytes by directly interacting with their receptor for activation. J. Immunol. 128: 337-342, 1982

8) HESS, A. D. & P. J. TUTSCHKA: Effect of Cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J. Immunol. 124: 2601-2608, 1980

9) HESS, A. D.; P. J. TUTSCHKA & G. W. SANTOS: Effect of Cyclosporin A on human lymphocyte response in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J. Immunol. 126: 961-968, 1981

10) GILLIS, S. & K. A. SMITH: Long term culture of tumourspecific cytotoxic T cells. Nature 268: 154-156, 1977

11) PINTER, N. B.: Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. Gen. Virol. 5: 419-427, 1969

12) HAYRY, P.; L. C. ANDERSSON, S. NORDLING & M. VIROLAINEN: Allograft response in vitro. Tansplant. Rev. 12:91-140,1972

13) KASAHARA, T.; J. J. HOOKS, S. F. DOUGHERTY & J. J. OPPENHEIM: Interleukin 2-mediated immune interferon (INF) production by human T cells and T cell subsets. J. Immunol. 130: 1784-1789, 1983

14) JOHNSON, H. M. & W. L. FARRAR: The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol. 75: 154-159, 1983

15) BAKER, P. E.; S. GILLIS, M. M. FERM & K. A. SMITH: The effect of T cell growth factor on the generation of cytolytic T cells. J. Immunol. 121: 2168-2173, 1978

16) ABBUD-FILHO, M.; J. W. KUPIEC-WEGLINSKI, J. L. ARAUJO, C. D. HEIDECKE, N. L. TILNEY & T. B. STROM: Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL1, IL2, IL3): A role for IL3 in graft tolerance? J. Immunol. 133: 2582-2586, 1984

Content from these authors

Cited by (585)

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!